Page last updated: 2024-10-24

busulfan and Leukemia, Radiation-Induced

busulfan has been researched along with Leukemia, Radiation-Induced in 7 studies

Leukemia, Radiation-Induced: Leukemia produced by exposure to IONIZING RADIATION or NON-IONIZING RADIATION.

Research Excerpts

ExcerptRelevanceReference
"In polycythemia vera (PV), treatment with chlorambucil and radioactive phosphorus (p32) increases the risk of leukemic transformation from 1% to 13-14%."7.69Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. ( Fisher, SG; Godwin, J; Nand, S; Stock, W, 1996)
"In polycythemia vera (PV), treatment with chlorambucil and radioactive phosphorus (p32) increases the risk of leukemic transformation from 1% to 13-14%."3.69Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. ( Fisher, SG; Godwin, J; Nand, S; Stock, W, 1996)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19903 (42.86)18.7374
1990's4 (57.14)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brandt, L1
Anderson, H1
Franco, E1
Alvarez, R1
Cuesta, I1
Aguilar, C1
Nand, S1
Stock, W1
Godwin, J1
Fisher, SG1
Sánchez Fayos, J1
Román Barbero, A1
Nevado Reviriego, I1
MacDougall, BK1
Weinerman, BH1
Kemel, S1
Vallée, G1
Boivin, P1
Dormont, J1
Soulier, JP1

Reviews

1 review available for busulfan and Leukemia, Radiation-Induced

ArticleYear
[Efficacious treatment of a fatal blood disease: polycythemia vera].
    Sangre, 1997, Volume: 42, Issue:3

    Topics: Acute Disease; Alkylating Agents; Busulfan; Chlorambucil; Humans; Hydroxyurea; Leukemia, Myeloid; Le

1997

Other Studies

6 other studies available for busulfan and Leukemia, Radiation-Induced

ArticleYear
Survival and risk of leukaemia in polycythaemia vera and essential thrombocythaemia treated with oral radiophosphorus: are safer drugs available?
    European journal of haematology, 1995, Volume: 54, Issue:1

    Topics: Administration, Oral; Aged; Busulfan; Female; Humans; Hydroxyurea; Leukemia, Myeloid, Acute; Leukemi

1995
[Chronic myeloid leukemia (CML) and solid neoplasms. Description of 3 cases].
    Sangre, 1994, Volume: 39, Issue:1

    Topics: Aged; Breast Neoplasms; Busulfan; Carcinoma, Hepatocellular; Combined Modality Therapy; Fatal Outcom

1994
Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
    American journal of hematology, 1996, Volume: 52, Issue:1

    Topics: Acute Disease; Anemia, Refractory, with Excess of Blasts; Busulfan; Cell Transformation, Neoplastic;

1996
Treatment of polycythemia vera.
    Canadian Medical Association journal, 1979, Sep-08, Volume: 121, Issue:5

    Topics: Acute Disease; Adult; Aged; Bloodletting; Busulfan; Evaluation Studies as Topic; Female; Humans; Leu

1979
[Present treatment of the Vaquez's disease].
    La Presse medicale, 1969, Mar-22, Volume: 77, Issue:14

    Topics: Aged; Anemia; Anticoagulants; Antineoplastic Agents; Blood Donors; Blood Volume; Bloodletting; Busul

1969
Treatment of polycythaemia vera.
    British medical journal, 1966, Jul-23, Volume: 2, Issue:5507

    Topics: Busulfan; Humans; Leukemia, Radiation-Induced; Phosphorus Isotopes; Polycythemia Vera; Pyrimethamine

1966